ஆர்கநைஸேஶந் ஆஃப் மருந்து ப்ரொட்யூஸர்ஸ் இந்தியா News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஆர்கநைஸேஶந் ஆஃப் மருந்து ப்ரொட்யூஸர்ஸ் இந்தியா. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஆர்கநைஸேஶந் ஆஃப் மருந்து ப்ரொட்யூஸர்ஸ் இந்தியா Today - Breaking & Trending Today

IP waiver proposal may open door to counterfeits: OPPI - The Hindu BusinessLine


As a global proposal from India and South Africa to waive intellectual property (IP) on Covid-19-linked health technologies garners support, the Organisation of Pharmaceutical Producers of India (OPPI) has countered that such a move “will neither lead to increased production of vaccines nor increased deployment”. Instead, they caution, it could open the door for counterfeit vaccines.
OPPI’s response comes days after the US put its might behind the IP waiver for vaccines during the pandemic period, a move that is expected to swing the support of other countries that may have earlier opposed the proposal at the WTO. ....

South Africa , Organisation Of Pharmaceutical Producers India , Serum Institute Of India , Pharmaceutical Producers , Serum Institute , ஆர்கநைஸேஶந் ஆஃப் மருந்து ப்ரொட்யூஸர்ஸ் இந்தியா , சீரம் நிறுவனம் ஆஃப் இந்தியா , மருந்து ப்ரொட்யூஸர்ஸ் , சீரம் நிறுவனம் ,

DCGI urged to not accept data from "discredited test" for depression drugs


DCGI urged to not accept data from “discredited test” for depression drugs
March 07, 2021
Large pharma companies have abandoned the “forced swim test” for mood disorder drugs
A “near drowning” test that uses small animals in the testing for depression and mood disorder drugs has come in for criticism, with pro-animal groups approaching the Drug Controller General of India (DCGI). The test that has been stopped by some international pharmaceutical companies.
In fact, the DCGI is said to have sought responses from three pharmaceutical associations on a representation from the People for the Ethical Treatment of Animals (PETA) on the “forced swim test” (FST). ....

India Research Associate Dr Ankita Pandey , Indian Pharmaceutical Alliance , Boehringer Ingelheim , Organisation Of Pharmaceutical Producers India , Indian Drug Manufacturer Association , Abbvie Inc , Bristol Myers Squibb , Novo Nordisk , Drug Controller General , Ethical Treatment , Pharmaceutical Producers , Research Associate Dr Ankita Pandey , International Council , Technical Requirements , Human Use , Astraea Therapeutics , Sage Therapeutics , Pfizer Managing Directors Sridhar , Clinical Trials , Animal Testing , Forced Swim Test , Depression Drugs , Pharma Companies , இந்தியா ஆராய்ச்சி இணை டாக்டர் அன்கிட்ட பாண்டே , இந்தியன் மருந்து கூட்டணி , போஹெரிங்கர் இஂகல்‌ஹைம் ,

OPPI Elects S Sridhar As President


BW Businessworld
OPPI Elects S Sridhar As President
Sridhar is the Managing Director of Pfizer and is heading the company s commercial business in India
Photo Credit : Reuters
Industry body Organisation of Pharmaceutical Producers of India (OPPI) on Monday said it has elected S Sridhar as its next President for a period of two years, effective from February 15, 2021.
He takes over from former Managing Director of Boehringer Ingelheim India, Sharad Tyagi, OPPI said in a statement.
Sridhar is the Managing Director of Pfizer and is heading the company s commercial business in India, it added.
He has been a member of the Executive Committee of OPPI for the past six years and has also chaired its Finance and Taxation Work Group, OPPI said. ....

Sharad Tyagi , Taxation Work Group , Organisation Of Pharmaceutical Producers India , Pharmaceutical Producers , Managing Director , Boehringer Ingelheim India , Executive Committee , Chartered Accountant , Ms Sridhar , Pharmaceutical Industry , ஷரத் தியாகி , வரிவிதிப்பு வேலை குழு , ஆர்கநைஸேஶந் ஆஃப் மருந்து ப்ரொட்யூஸர்ஸ் இந்தியா , மருந்து ப்ரொட்யூஸர்ஸ் , நிர்வகித்தல் இயக்குனர் , போஹெரிங்கர் இஂகல்‌ஹைம் இந்தியா , நிர்வாகி குழு , பட்டய கணக்கர் , கள் ஸ்ரீதர் , மருந்து தொழில் ,

OPPI elects S Sridhar as new President


OPPI elects S Sridhar as new President
OPPI elects S Sridhar as new President
15 February 2021 | News
Sridhar is the Managing Director of Pfizer Limited and is heading Pfizer Inc’s commercial business in India
The Organisation of Pharmaceutical Producers of India (OPPI) has elected S Sridhar as its next President. The term is for a period of two years and is effective from February 15, 2021. He takes over from Sharad Tyagi, Former Managing Director, Boehringer Ingelheim India Pvt Ltd. Sridhar is the Managing Director of Pfizer Limited and is heading Pfizer Inc’s commercial business in India. Sridhar has been a member of the Executive Committee of OPPI for the past six years and has also chaired its Finance and Taxation Work Group. Sridhar is a strong voice of healthcare transformation in the country and was the chair of FICCI’s Pharma Committee till recently.  ....

Sharad Tyagi , Boehringer Ingelheim India Pvt Ltd , Pfizer Inc , Taxation Work Group , Pfizer Ltd , Organisation Of Pharmaceutical Producers India , Pharma Committee , Pharmaceutical Producers , Former Managing Director , Boehringer Ingelheim India Pvt , Managing Director , Pfizer Limited , Executive Committee , Taxation Work , Chartered Accountant , Chief Financial Officer , Business Unit , India Commercial Business , Ms Sridhar , ஷரத் தியாகி , போஹெரிங்கர் இஂகல்‌ஹைம் இந்தியா பிரைவேட் லிமிடெட் , ஃபைசர் இன்க் , வரிவிதிப்பு வேலை குழு , ஃபைசர் லிமிடெட் , ஆர்கநைஸேஶந் ஆஃப் மருந்து ப்ரொட்யூஸர்ஸ் இந்தியா , பார்மா குழு ,